Source: Annual Congress 2012 - COPD inflammation and genes
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Hoshika, F. Takahashi, S. Togo, M. Hashimoto, T. Kobayashi, H. Kataoka, M. Kurihara, E. Kobayashi, K. Ando, K. Seyama, K. Takahashi (Tokyo, Japan). Lung fibroblast function in patients with Birt-Hogg-Dubé syndrome. Eur Respir J 2012; 40: Suppl. 56, 4806

Member's Comments

No comment yet.

Related content which might interest you: Lung function in Birt-Hogg-Dubé syndrome Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Lung function decline in patients with severe alpha1-antitrypsin deficiency Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Long term follow-up of Greek patients with pulmonary sarcoidosis. Relation to transforming growth factor-beta genetic profile Source: International Congress 2014 – ILDs 3 Year: 2014 Lymphangioleiomyomatosis: Functional and morphological characteristics in 36 patients Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Regulation of vascular endothelial growth factor expression in a mouse model of acute respiratory distress syndrome (ARDS) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Lung function at patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 Nintedanib prevents IL-1beta-stimulated proliferation of primary human lung fibroblasts from patients with idiopathic pulmonary fibrosis or from control donors Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry Source: International Congress 2016 – Paediatric bronchology I Year: 2016 Matriptase triggers pleiotropic functional responses in normal human lung fibroblasts (NHLF): Potential relevance in pathophysiology Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Neoplasia in patients with ILD; shortened survival Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Association of lung function and body composition in patients with metabolic syndrome Source: International Congress 2014 – Physiotherapy assessment and techniques in respiratory and non-respiratory conditions Year: 2014 Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Cell therapy for the treatment of acute lung injury: Alveolar type II cells or mesenchymal stem cells? Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Pleuroparenchymal fibroelastosis (PPFE) – Resembling features in patients with malignancies Source: International Congress 2015 – IIPs: orphan Year: 2015 Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014